Ionis Pharmaceuticals
IONS
IONS
392 hedge funds and large institutions have $9.53B invested in Ionis Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 94 funds opening new positions, 107 increasing their positions, 127 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
392
Holders Change
+63
Holders Change %
+19.15%
% of All Funds
8.5%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.22%
New
94
Increased
107
Reduced
127
Closed
29
Calls
$109M
Puts
$223M
Net Calls
-$114M
Net Calls Change
-$65.7M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$107M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$52.3M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$32.3M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$30.1M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$27.2M |
Top Sellers
| 1 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
-$82.5M |
| 2 |
ClearBridge Investments
New York
|
-$71.6M |
| 3 |
Goldman Sachs
New York
|
-$56.3M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$39.2M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$24.7M |
